Kane CT - Search Results

1

Changes in the renal function after tenofovir-containing antiretroviral therapy initiation in a Senegalese cohort (ANRS 1215).

De Beaudrap P, Diallo MB, Landman R, Guèye NF, Ndiaye I, Diouf A, Kane CT, Etard JF, Girard PM, Sow PS, Delaporte E; ANRS 1215 Study Group. De Beaudrap P, et al. Among authors: kane ct. AIDS Res Hum Retroviruses. 2010 Nov;26(11):1221-7. doi: 10.1089/aid.2009.0261. Epub 2010 Sep 21. AIDS Res Hum Retroviruses. 2010. PMID: 20854202

2

Full-length genome sequencing of HIV type 1 group O viruses isolated from a heterosexual transmission cluster in Senegal.

Kane CT, Montavon C, Toure MA, Faye MA, Ndiaye AG, Diallo AG, Ndoye I, Liegeois F, Delaporte E, Mboup S, Peeters M. Kane CT, et al. AIDS Res Hum Retroviruses. 2001 Aug 10;17(12):1211-6. doi: 10.1089/088922201316912817. AIDS Res Hum Retroviruses. 2001. PMID: 11522190

3

No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.

Laurent C, Bourgeois A, Faye MA, Mougnutou R, Seydi M, Gueye M, Liégeois F, Kane CT, Butel C, Mbuagbaw J, Zekeng L, Mboup S, Mpoudi-Ngolé E, Peeters M, Delaporte E. Laurent C, et al. Among authors: kane ct. J Infect Dis. 2002 Aug 15;186(4):486-92. doi: 10.1086/341833. Epub 2002 Jul 19. J Infect Dis. 2002. PMID: 12195375

4

Once-a-day highly active antiretroviral therapy in treatment-naive HIV-1-infected adults in Senegal.

Landman R, Schiemann R, Thiam S, Vray M, Canestri A, Mboup S, Kane CT, Delaporte E, Sow PS, Faye MA, Gueye M, Peytavin G, Dalban C, Girard PM, Ndoye I; Imea 011/ANRS 12-04 Study Group. Landman R, et al. Among authors: kane ct. AIDS. 2003 May 2;17(7):1017-22. doi: 10.1097/00002030-200305020-00010. AIDS. 2003. PMID: 12700451 Clinical Trial.

5

Low rate of genotypic HIV-1 drug-resistant strains in the Senegalese government initiative of access to antiretroviral therapy.

Vergne L, Kane CT, Laurent C, Diakhaté N, Gueye NF, Gueye PM, Sow PS, Faye MA, Liégeois F, Ndir A, Lanièce I, Peeters M, Ndoye I, Mboup S, Delaporte E. Vergne L, et al. Among authors: kane ct. AIDS. 2003 Jul;17 Suppl 3:S31-8. doi: 10.1097/00002030-200317003-00005. AIDS. 2003. PMID: 14565607

6

Quantitation of HIV-1 RNA in dried blood spots by the real-time NucliSENS EasyQ HIV-1 assay in Senegal.

Kane CT, Ndiaye HD, Diallo S, Ndiaye I, Wade AS, Diaw PA, Gaye-Diallo A, Mboup S. Kane CT, et al. J Virol Methods. 2008 Mar;148(1-2):291-5. doi: 10.1016/j.jviromet.2007.11.011. Epub 2008 Feb 1. J Virol Methods. 2008. PMID: 18242718

7

Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal.

Canestri A, Sow PS, Vray M, Ngom F, M'boup S, Kane CT, Delaporte E, Gueye M, Peytavin G, Girard PM, Landman R; ANRS 12-06/IMEA 012 Trial Study Group. Canestri A, et al. Among authors: kane ct. MedGenMed. 2007 Oct 9;9(4):7. MedGenMed. 2007. PMID: 18311357 Free PMC article. Clinical Trial.

8

Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal.

Canestri A, Sow PS, Vray M, Ngom F, M'boup S, Kane CT, Delaporte E, Gueye M, Peytavin G, Girard PM, Landman R; ANRS 12-06/IMEA 012 Trial Study Group. Canestri A, et al. Among authors: kane ct. J Int AIDS Soc. 2007 Oct 9;9(4):7. doi: 10.1186/1758-2652-9-4-7. J Int AIDS Soc. 2007. PMID: 19825141 Free PMC article.

9

Low prevalence of HIV type 1 drug resistance mutations in untreated, recently infected patients from Burkina Faso, Côte d'Ivoire, Senegal, Thailand, and Vietnam: the ANRS 12134 study.

Ayouba A, Lien TT, Nouhin J, Vergne L, Aghokeng AF, Ngo-Giang-Huong N, Diop H, Kane CT, Valéa D, Rouet F, Joulia-Ekaza D, Toni TD, Nerrienet E, Ngole EM, Delaporte E, Costagliola D, Peeters M, Chaix ML. Ayouba A, et al. Among authors: kane ct. AIDS Res Hum Retroviruses. 2009 Nov;25(11):1193-6. doi: 10.1089/aid.2009.0142. AIDS Res Hum Retroviruses. 2009. PMID: 19886834

10

Efficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal.

Landman R, Diallo MB, Gueye NF, Kane CT, Mboup S, Fall MB, Ndiaye B, Peytavin G, Bennai Y, Benalycherif A, Girard PM, Sow PS. Landman R, et al. Among authors: kane ct. AIDS Res Hum Retroviruses. 2010 May;26(5):519-25. doi: 10.1089/aid.2009.0123. AIDS Res Hum Retroviruses. 2010. PMID: 20455760 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters